The rise and rise of GLP-1 weight loss medications: Will they fall?
Louise Martin explores the promise and pitfalls of the weight-loss drugs taking the world by storm, weighing benefits against hidden costs.
medicine
Continue reading
GLP-1s: Quick fix or health revolution?
Maisie Burrow-Hills explores the impact of GLP-1 drugs on societal attitudes, mental health and inequality
Nano-medicine listening for ultra-sound: A promising design against liver cancer
Sebastian Evans reports on the development of a biodegradable nanoparticle that can slow the progression of hepatocellular carcinoma.
French lab develops a new drug against chronic bowel inflammatory diseases
Marie Werner reports on the development of a new RNA-targeting drug that could reshape treatment for ulcerative colitis.
Health is more than medicine: the CMO’s report on health in cities
Magnus Page details the UK chief medical officer’s report on health in cities, discussing the role economic deprivation has on health.
Novel male contraceptives — hormonal or non-hormonal? A summary of research and new developments
Will Jackson reports on novel male contraceptives research developments, covering associated benefits and drawbacks.
CRISPR? That was so last year: Introducing the Bridge recombinase mechanism
Louise Martin reports on the novel genetic editing technique, the bridge recombinase mechanism, which may outshine CRISPR.
First US bird flu death: Pandemic precursor or viral commotion?
Adam Grassly reports on the recent outbreak of bird flu and measures that can be taken to prevent future pandemics.
Timing is everything: The power of chronotherapy
Leah Fogarty explores the clinical potential of chronotherapy, where treatment is optimised based on the time of day.
Hidden talent turned scientific superpower: The woman who can smell Parkinson’s
Corenna Twiss reflects on the story of Joy Milne, the woman who can smell Parkinson’s Disease, and the potential implications.
